Antibiotic susceptibility profiles of neonatal invasive isolates of Escherichia coli from a 2-year nationwide surveillance study in Germany, 2009-2010

Eur J Clin Microbiol Infect Dis. 2013 Sep;32(9):1221-3. doi: 10.1007/s10096-013-1871-3. Epub 2013 Apr 5.


A nationwide 2-year surveillance study on invasive neonatal Escherichia coli infections in Germany was conducted. A total of 158 isolates were tested for antibiotic susceptibility. The empirical treatment regimen of ampicillin plus gentamicin for neonatal sepsis appears to remain effective, but emerging resistance needs to be closely monitored.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / therapeutic use*
  • Drug Resistance, Bacterial
  • Epidemiological Monitoring
  • Escherichia coli / drug effects*
  • Escherichia coli Infections / drug therapy*
  • Escherichia coli Infections / epidemiology*
  • Escherichia coli Infections / microbiology
  • Germany / epidemiology
  • Humans
  • Infant, Newborn
  • Microbial Sensitivity Tests


  • Anti-Bacterial Agents